Low-Cost User-Friendly Otoacoustic Emissions Probe
低成本、用户友好的耳声发射探头
基本信息
- 批准号:9243238
- 负责人:
- 金额:$ 70.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-07 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdult Acute Lymphocytic LeukemiaAgeAlgorithmsAmericanAttenuatedAudiologyBiologicalCellular PhoneChildClinicClinicalClinical ProtocolsCommunication impairmentCommunitiesComputer softwareConchaControlled EnvironmentCost SavingsCountryDeveloping CountriesDevelopmentDevicesDiagnosticEarEarmuffElectronicsEnvironmentEvaluationExternal auditory canalFamilyFeedbackFundingGovernmentHeadHealthHealth ServicesHealthcareHearingHearing problemHome environmentHuman ResourcesImpairmentImprove AccessIndividualInfantIntellectual functioning disabilityInternationalInternetLettersLicensingLocationMeasurementMeasuresMedical StudentsMethodsMigrant WorkersMonitorNoiseNomadsNursesPatientsPerformancePeripheralPersonsPhasePopulationProtocols documentationPublic HealthRecruitment ActivityReportingResourcesSchoolsSignal TransductionStimulusStudentsStudy SubjectSurveysSystemTabletsTarget PopulationsTechnologyTelephoneTest ResultTestingTimeTrainingUnderserved PopulationWireless TechnologyWorkbasebehavioral responsecohortcommercializationcomputerizedcostdeafnessdesigndigitalfarm workerfarmerhealth care availabilityhearing impairmenthearing screeninghelp-seeking behaviorhuman studyhuman subjectimprovedinnovationinnovative technologiesinterestmobile computingmonitoring deviceotoacoustic emissionportabilityprogramsprototypepublic health relevanceremote locationresponsescreeningtelehealthtoolusabilityuser-friendly
项目摘要
DESCRIPTION (provided by applicant): Hearing loss is a leading public health concern, with about 17% of American adults reporting some degree of impairment. Of those, fewer than 20% seek help for their condition for a variety of reasons. To address this issue, the National Institue of Deafness and Other Communication Disorders (NIDCD) is seeking solutions to improve hearing healthcare access and lower its cost. Solutions include enabling currently available commodities (telephone, Internet, and smartphones) to conduct surveillance of hearing loss, Internet screening systems, and DPOAE screening to be used beyond traditional clinical environments. Creare proposes to complete development of a hearing screening device that measures Otoacoustic Emissions and is controlled through a mobile platform. Our device is designed for use in remote and non- traditional locations with limited personnel and resources as well as for widespread infant screening in the developing world. OAE measurements can be successfully obtained even in noise environments thanks to our noise rejection algorithms as well as a design that enables the use of attenuating earmuffs over the probe to further reduce external noise. The device is designed for low-cost manufacturing and results in a screening system that is cost competitive with even the lowest cost audiometric screeners used in schools. The resulting device will provide a solution to the problem of hearing healthcare access for populations who are unable to provide behavioral responses by allowing wide-scale screening in public health programs and humanitarian efforts, as well as in remote locations where minimal resources are available. In addition, because it is designed for use with mobile platforms and is calibrated to applicable standards, the proposed device will enhance the development of quality audiology applications for use with smartphones, tablets, and the Internet. During Phase I, we demonstrated the feasibility of our innovation by building a benchtop prototype of the device and testing its performance using standard clinical protocols. We showed that DPOAEs measured with our prototype were equivalent to DPOAEs measured with a commercial device on a pilot human study that included 20 subjects. During Phase II, we will refine the design of our device, build several integrated prototypes, and demonstrate their use and performance with several human subject studies in target locations and populations. The Phase II human study will have two objectives: (1) compare the test results and test/retest variability using the new device to what can be achieved with existing commercial devices, and (2) evaluate the performance of our device in the target populations to demonstrate its ability to increase access to hearing health in underserved populations. The Creare team is extremely well qualified to successfully develop and commercialize this low-cost hearing screening device for automated and remote applications. Our system is made possible by leveraging hardware and software that Creare has previously developed for hearing assessment in varied settings including remote assessment in developing countries, Otoacoustic Emission (OAE) measurement in noisy environments, and advanced hearing protection.
描述(由申请人提供):听力损失是一个主要的公共卫生问题,大约 17% 的美国成年人报告有一定程度的听力损失,其中只有不到 20% 的人因各种原因寻求帮助来解决这一问题。针对这一问题,国家耳聋和其他沟通障碍研究所 (NIDCD) 正在寻求解决方案,以改善听力保健服务的可及性并降低其成本。 Creare 提议完成听力筛查设备的开发,该设备可测量耳声发射并通过移动平台进行控制。 - 得益于我们的噪声抑制算法以及能够在耳罩上方使用衰减耳罩的设计,即使在人员和资源有限的传统地点以及发展中国家广泛的婴儿筛查中,即使在噪声环境中也可以成功获得 OAE 测量结果。探测该设备专为低成本制造而设计,其筛查系统即使与学校使用的成本最低的听力筛查仪相比也具有成本竞争力,最终的设备将为听力保健获取问题提供解决方案。适用于无法通过公共卫生计划和人道主义工作进行大规模筛查以及在可用资源最少的偏远地区提供行为反应的人群。此外,因为它是专为与移动平台一起使用而设计的,并且经过了校准。根据适用的标准,拟议的设备将提高质量的发展在第一阶段,我们通过构建设备的台式原型并使用标准临床协议测试其性能来证明我们的创新的可行性。相当于在包括 20 名受试者的试点人体研究中使用商业设备测量的 DPOAE。在第二阶段,我们将改进设备的设计,构建多个集成原型,并通过在目标位置进行的多个人体受试者研究来展示其用途和性能。和人口。 II 人体研究将有两个目标:(1) 将使用新设备的测试结果和测试/重新测试变异性与现有商业设备所能达到的结果进行比较,以及 (2) 评估我们的设备在目标人群中的性能,以证明Creare 团队非常有能力成功开发这种用于自动化和远程应用的低成本听力筛查设备并将其商业化,我们的系统是通过利用 Creare 拥有的硬件和软件实现的。以前开发用于各种环境下的听力评估,包括远程评估发展中国家、噪声环境中的耳声发射 (OAE) 测量以及先进的听力保护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ODILE H CLAVIER其他文献
ODILE H CLAVIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ODILE H CLAVIER', 18)}}的其他基金
A Wireless Audiometric Headset that Integrates Hearing Testing, Education, and Personalized Hearing Protection Fitting
集听力测试、教育和个性化听力保护验配于一体的无线测听耳机
- 批准号:
10367463 - 财政年份:2020
- 资助金额:
$ 70.71万 - 项目类别:
Diagnostic Hearing Test System for Telehealth in Underserved Communities
用于服务欠缺社区远程医疗的诊断听力测试系统
- 批准号:
10255432 - 财政年份:2019
- 资助金额:
$ 70.71万 - 项目类别:
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Gra
PHS 2018-02 NIH、CDC 和 FDA 小型企业创新研究综合征集
- 批准号:
10158773 - 财政年份:2019
- 资助金额:
$ 70.71万 - 项目类别:
Diagnostic Hearing Test System for Telehealth in Underserved Communities
用于服务欠缺社区远程医疗的诊断听力测试系统
- 批准号:
10452703 - 财政年份:2019
- 资助金额:
$ 70.71万 - 项目类别:
STEM Interactive Digital Tool to Educate and Promote Hearing Health and Science for 4th to 7th Grade
用于教育和促进 4 至 7 年级听力健康和科学的 STEM 交互式数字工具
- 批准号:
9789356 - 财政年份:2016
- 资助金额:
$ 70.71万 - 项目类别:
Low-Cost User-Friendly Otoacoustic Emissions Probe
低成本、用户友好的耳声发射探头
- 批准号:
8754205 - 财政年份:2014
- 资助金额:
$ 70.71万 - 项目类别:
Wireless and Noise Attenuating Headset for Automated Hearing Screening
用于自动听力筛查的无线降噪耳机
- 批准号:
8432582 - 财政年份:2012
- 资助金额:
$ 70.71万 - 项目类别:
Adherence Monitoring for Substance Abuse Clinical Trials
药物滥用临床试验的依从性监测
- 批准号:
8315218 - 财政年份:2012
- 资助金额:
$ 70.71万 - 项目类别:
相似国自然基金
去泛素化酶USP5调控P53通路在伴E2A-PBX1成人ALL的致病机制研究
- 批准号:81900151
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
核基质结合区蛋白SATB1调控CCR7抑制急性T淋巴细胞白血病中枢浸润的作用与机制
- 批准号:81870113
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
成人及儿童急性淋巴细胞白血病的基因组转录组生物信息学分析方法建立及数据分析
- 批准号:81570122
- 批准年份:2015
- 资助金额:60.0 万元
- 项目类别:面上项目
NR3C1基因突变在成人急性淋巴细胞白血病耐药与复发中的作用与机制研究
- 批准号:81470309
- 批准年份:2014
- 资助金额:75.0 万元
- 项目类别:面上项目
成人急性淋巴细胞白血病逃逸机体免疫系统杀伤的机制研究
- 批准号:30971297
- 批准年份:2009
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 70.71万 - 项目类别:
Feasibility of a mobile application for sleep and circadian rhythms in pediatric patients with acute lymphoblastic leukemia and their caregivers
急性淋巴细胞白血病儿科患者及其护理人员睡眠和昼夜节律移动应用程序的可行性
- 批准号:
10603223 - 财政年份:2023
- 资助金额:
$ 70.71万 - 项目类别:
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations
定义 Ph 样 ALL 基因组重排机制以确定高危西班牙裔人群的预测标记
- 批准号:
10347835 - 财政年份:2022
- 资助金额:
$ 70.71万 - 项目类别:
Genomics of childhood acute lymphoblastic leukemia in the Childhood Cancer and Leukemia International Consortium
儿童癌症和白血病国际联盟的儿童急性淋巴细胞白血病基因组学
- 批准号:
10688281 - 财政年份:2022
- 资助金额:
$ 70.71万 - 项目类别:
Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults with Leukemia
使用实时移动健康方法来了解和促进患有白血病的青少年和年轻人的口服化疗依从性
- 批准号:
10703839 - 财政年份:2022
- 资助金额:
$ 70.71万 - 项目类别: